Journal article
1327P First-line osimertinib in patients with EGFR mutated lung cancer with uncommon mutations (OCELOT study – interim analysis)
Authors
Breadner DA; Liu G; Rothenstein J; Verma S; Menjak I; Cheema PK; Juergens R; Mithoowani H; Bains P; Wang Y
Journal
Annals of Oncology, Vol. 34, ,
Publisher
Elsevier
Publication Date
October 1, 2023
DOI
10.1016/j.annonc.2023.09.2360
ISSN
0923-7534